Monday, August 31, 2026

Koninklijke Philips Stock Impressive Rise On Monday, Outperforms Market

Koninklijke Philips Stock  Impressive Rise On Monday, Outperforms Market

(VIANEWS) - The NYSE ended the session with Koninklijke Philips jumping 14.29% to $21.75 on Monday, following the last session's upward trend. NYSE rose 0.18% to $15,606.71, after three successive sessions in a row of losses, on what was a somewhat positive trend trading session today.

Koninklijke Philips's last close was $19.03, 38.73% below its 52-week high of $31.06.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings Per Share

As for profitability, Koninklijke Philips has a trailing twelve months EPS of $-2.02.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -11.66%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on May 11, 2022, the estimated forward annual dividend rate is 0.91 and the estimated forward annual dividend yield is 4.91%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Koninklijke Philips's stock is considered to be oversold (<=20).

Volatility

Koninklijke Philips's last week, last month's, and last quarter's current intraday variation average was 1.13%, 1.01%, and 1.76%.

Koninklijke Philips's highest amplitude of average volatility was 1.34% (last week), 1.71% (last month), and 1.76% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.7%, now sitting on 17.83B for the twelve trailing months.

More news about Koninklijke Philips (PHG).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com